Literature DB >> 24930007

URG11 predicts poor prognosis of pancreatic cancer by enhancing epithelial-mesenchymal transition-driven invasion.

Wei Peng1, Jun Zhang, Jie Liu.   

Abstract

The poor prognosis and high recurrent rate of pancreatic cancer (PC) necessitates the discovery of new predictive markers of PC invasion and prognosis. In this study, we evaluated the expression pattern of up-regulated gene 11 (URG11) in a tissue microarray with 18 pairs of PC and adjacent normal tissues. It was shown that URG11 was significantly up-regulated in PC tissues. High expression levels of URG11 were detected in all PC specimens, but were rarely detected in adjacent non-tumorous tissues. In addition, high expression of URG11 was correlated to poor prognosis. Furthermore, it was discovered that URG11 was correlated to epithelial-mesenchymal transition (EMT) markers and clinical pathological parameters indicative of high PC invasion, while knockdown of URG11 significantly changed the expression pattern of EMT markers and decreased the invasion of PC cells. These findings indicate that URG11 might enhance the invasion of PC by inducing EMT and thus lead to poor PC prognosis. Thus, URG11 has the potential to be a new predictive biomarker of PC invasion and prognosis, which may help in the diagnosis and treatment of PC patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24930007     DOI: 10.1007/s12032-014-0064-y

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  17 in total

Review 1.  Pancreatic cancer.

Authors:  Manuel Hidalgo
Journal:  N Engl J Med       Date:  2010-04-29       Impact factor: 91.245

2.  Adenoviral-mediated RNA interference targeting URG11 inhibits growth of human hepatocellular carcinoma.

Authors:  Rui Fan; Xiaohua Li; Wenqi Du; Xue Zou; Rui Du; Lina Zhao; Guanhong Luo; Ping Mo; Lin Xia; Yanglin Pan; Yongquan Shi; Zhaorui Lian; Mark A Feitelson; Yongzhan Nie; Jie Liu; Daiming Fan
Journal:  Int J Cancer       Date:  2010-10-08       Impact factor: 7.396

Review 3.  Current management of locally advanced pancreatic cancer.

Authors:  Vivek Maheshwari; A James Moser
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-08

4.  Aberrant elevated microRNA-146a in dendritic cells (DC) induced by human pancreatic cancer cell line BxPC-3-conditioned medium inhibits DC maturation and activation.

Authors:  Jian Du; Jingwen Wang; Guang Tan; Zhengang Cai; Lu Zhang; Bo Tang; Zhongyu Wang
Journal:  Med Oncol       Date:  2012-02-07       Impact factor: 3.064

5.  Enhanced cell survival of Hep3B cells by the hepatitis B x antigen effector, URG11, is associated with upregulation of beta-catenin.

Authors:  Zhaorui Lian; Jie Liu; Li Li; Xianxing Li; Marcy Clayton; Meng-Chao Wu; Hong-Yang Wang; Patrick Arbuthnot; Michael Kew; Daiming Fan; Mark A Feitelson
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

Review 6.  FOLFIRINOX for locally advanced and metastatic pancreatic cancer: single institution retrospective review of efficacy and toxicity.

Authors:  Krishna S Gunturu; Xiaopan Yao; Xiangyu Cong; Jaykumar R Thumar; Howard S Hochster; Stacey M Stein; Jill Lacy
Journal:  Med Oncol       Date:  2012-12-28       Impact factor: 3.064

Review 7.  Recent progress in pancreatic cancer.

Authors:  Christopher L Wolfgang; Joseph M Herman; Daniel A Laheru; Alison P Klein; Michael A Erdek; Elliot K Fishman; Ralph H Hruban
Journal:  CA Cancer J Clin       Date:  2013-07-15       Impact factor: 508.702

8.  URG11 mediates hypoxia-induced epithelial-to-mesenchymal transition by modulation of E-cadherin and beta-catenin.

Authors:  Rui Du; Chen Huang; Qian Bi; Ying Zhai; Lin Xia; Jie Liu; Shiren Sun; Daiming Fan
Journal:  Biochem Biophys Res Commun       Date:  2009-11-11       Impact factor: 3.575

9.  Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial-mesenchymal transition.

Authors:  Lu He; Xinke Zhou; Chen Qu; Lijuan Hu; Yunqiang Tang; Qiong Zhang; Min Liang; Jian Hong
Journal:  J Cell Mol Med       Date:  2013-10-31       Impact factor: 5.310

10.  URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway.

Authors:  Rui Du; Lin Xia; Shiren Sun; Zhaorui Lian; Xue Zou; Juan Gao; Huahong Xie; Rui Fan; Jiugang Song; Xiaohua Li; Jie Liu; Daiming Fan
Journal:  J Cell Mol Med       Date:  2008-12-24       Impact factor: 5.310

View more
  7 in total

1.  LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy.

Authors:  Wei Peng; Jianzhong Wu; Jifeng Feng
Journal:  Clin Exp Med       Date:  2015-10-16       Impact factor: 3.984

2.  LncRNA NEAT1 Impacts Cell Proliferation and Apoptosis of Colorectal Cancer via Regulation of Akt Signaling.

Authors:  Wei Peng; Zhuo Wang; Hong Fan
Journal:  Pathol Oncol Res       Date:  2016-12-24       Impact factor: 3.201

3.  VWCE as a potential biomarker associated with immune infiltrates in breast cancer.

Authors:  Qin Huo; Zhenwei Li; Siqi Chen; Juan Wang; Jiaying Li; Ni Xie
Journal:  Cancer Cell Int       Date:  2021-05-21       Impact factor: 5.722

4.  URG11 Regulates Prostate Cancer Cell Proliferation, Migration, and Invasion.

Authors:  Bin Pan; Yunlin Ye; Haiping Liu; Jianli Zhen; Hongmei Zhou; Yutong Li; Lijun Qu; Youke Wu; Chuanrong Zeng; Weifeng Zhong
Journal:  Biomed Res Int       Date:  2018-05-31       Impact factor: 3.411

5.  URG11 promotes proliferation and induced apoptosis of LNCaP cells.

Authors:  Chenmin Sun; Guangming Zhang; Shujie Cheng; Haining Qian; Dong Li; Min Liu
Journal:  Int J Mol Med       Date:  2019-03-05       Impact factor: 4.101

6.  Monosomy 3 Influences Epithelial-Mesenchymal Transition Gene Expression in Uveal Melanoma Patients; Consequences for Liquid Biopsy.

Authors:  Andrea Soltysova; Tatiana Sedlackova; Dana Dvorska; Karin Jasek; Pooneh Chokhachi Baradaran; Viera Horvathova Kajabova; Lucia Demkova; Verona Buocikova; Terezia Kurucova; Darina Lyskova; Alena Furdova; Gabriel Minarik; Pavel Babal; Zuzana Dankova; Bozena Smolkova
Journal:  Int J Mol Sci       Date:  2020-12-17       Impact factor: 5.923

7.  VWCE Functions as a Tumor Suppressor in Breast Cancer Cells.

Authors:  Dan Zhang; Lili Wan; Fan Yang; Wenlan Liu; Litao Liu; Shengnan He; Ni Xie
Journal:  Front Oncol       Date:  2020-10-22       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.